Could Avian H5N1 Influenza be Disease X for the Bio-Pharmaceutical Complex?

Fear Mongering, Food Supply Threat, Virus with a Deadly Past, BARDA Self-Amplifying mRNA Vaccines—A Perfect Storm is Brewing

By Dr. Peter McCullough and Nicolas Hulscher

With the fear-mongering campaign of ‘Disease X’ sponsored by the Coalition for Epidemic Preparedness and Innovation (CEPI), people are wondering what virus might infect the world next. A few days ago, the CDC issued a health advisory for the H5N1 bird flu as it was detected in a Texas dairy farm worker [1]. His only symptom was conjunctivitis, or inflammation of the eye. As of today, human-to-human transmission has not occurred and thus H5N1 poses limited risk to humans. However, this may change in the near future, especially if we consider the dark history of gain of function (GOF) research regarding H5N1.

Over a decade ago, the National Institutes of Health (NIH) and the Bill and Melinda Gates Foundation funded GOF research that made H5N1 more transmissible [2]. One of the primary authors of this dangerous research is Yoshihiro Kawaoka, who is affiliated with the University of Wisconsin-Madison and University of Tokyo. Another player is Ron Fouchier, working at the Erasmus medical center in the Netherlands [2]. These two have a deep history of modifying viruses in laboratories and infecting animals with various types of pathogens. This research prompted a short pause on GOF research funding by the US government to assess risks [3]. A few years later, in 2017, the NIH resumed funding GOF research [4] because the HHS P3CO Framework was released, detailing ‘safe’ methods to conduct dangerous research with modified pathogens [5]. Charostad, et al, in 2023 indicated that highly pathogenic avian influenza (H5N1) is an “imminent threat.”

With this pretext in 2020, the FDA approved the first H5N1 vaccine, Audenz, for ages 6 months and older [6]. This vaccine was developed by CSL Seqirus, a company funded by the Biomedical Advanced Research and Development Authority (BARDA) [7]. The first generation product comes from a cell-based, combination inactive antigen platform. The second generation is planned to be self-amplifying mRNA (sa-mRNA) technology. Perhaps there’s a reason the US government is already stockpiling an ‘approved’ vaccine for a virus that doesn’t spread in humans. The CDC alert does not mention the approved vaccine, saying that they will develop one if needed. Very strange.

“How mRNA vaccines could target everything from cancer to the plague”: They Will Never Stop, Even If Pfizer & Moderna COVID-19 mRNA Vaccines Were a Complete Failure

CEPI is similarly funding Korea’s Chungbuk National University (CBNU) to create novel sa-mRNA vaccines to combat H5N1. This new platform is basically current mRNA vaccines on steroids, with self replicating RNA causing massive amount of foreign protein.

Bill Gates and the World Economic Forum (WEF) believe we should reduce our reliance on animal food products [8,9] as part of their globalist views [10]. Thus, a food scare in westernized countries with market recalls and destruction of poultry and meat would further dystopian goals for the Davos club [11]. H5N1 has a historical fatality rate of 52.16% in humans and fear alone could drive considerable anxiety in large populations not only about exposure through food, but pets, and other humans [12].

It’s difficult to determine if H5N1 is the next ‘Disease X’ at the moment. It’s possible due to the abundance of GOF research and biotech interests, ready-made vaccines, and powerful drivers of mass panic in the wings. If more cases occur in clusters or bona fide outbreaks with human-to-human transmission, we could be well on our way to a 2024 avian influenza pandemic crisis.

Note to readers: Please click the share button above. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.

Notes

1. https://emergency.cdc.gov/han/2024/han00506.asp

2. https://www.ncbi.nlm.nih.gov/books/NBK206985/

3. https://obamawhitehouse.archives.gov/blog/2014/10/17/doing-diligence-assess-risks-and-benefits-life-sciences-gain-function-research

4. https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-lifts-funding-pause-gain-function-research

5. https://www.phe.gov/s3/dualuse/Documents/p3co.pdf

6. https://www.fda.gov/media/135020/download#:~:text=in%20the%20vaccine.-,AUDENZ%20is%20approved%20for%20use%20in%20persons%206%20months%20of,subtype%20contained%20in%20the%20vaccine.&text=Administer%20two%20doses%20of%20AUDENZ,each)%2C%2021%20days%20apart.

7. https://www.cslseqirus.us/news/csl-seqirus-us-government-award-to-manufacture-and-assess-influenza-a-h5n8-pre-pandemic-vaccine

8. https://www.technologyreview.com/2021/02/14/1018296/bill-gates-climate-change-beef-trees-microsoft/

9. https://www.weforum.org/agenda/2019/06/you-will-be-eating-replacement-meats-within-20-years-heres-why/

10. https://www.weforum.org/agenda/2020/06/the-great-reset-this-weeks-world-vs-virus-podcast/

11. Innovating to zero! | Bill Gates